zomedica stock overview

Zomedica (stock)

Zomedica stock refers to the publicly traded equity of Zomedica Corp., a U.S.-based veterinary health company whose common shares are quoted over the counter under the ticker ZOMDF. This guide explains what Zomedica does, how the zomedica stock is listed and traded, where to find price and disclosure data, key financial and operational considerations, and how to follow company developments safely and efficiently.

As of 2026-01-27, according to OTC Markets and Zomedica investor communications, the company continues to provide investor materials and regulatory filings that are primary sources for up-to-date information on the zomedica stock. Readers should consult the issuer’s investor relations pages and official filings for the latest numeric details before making any decisions.

Company overview

Zomedica Corp. is focused on veterinary health products for companion animals and equine markets. The company develops diagnostics and therapeutics intended to support clinical decision-making and improve animal care.

Key elements of Zomedica’s business profile include:

• Product focus: point-of-care veterinary diagnostics and complementary therapeutics designed for clinics and veterinarians.
• Flagship platforms and brands: the TRUFORMA diagnostic platform and related cytology or point-of-care testing systems; product names associated with Zomedica have included instruments and consumables intended for in-clinic use.
• Market: primarily companion animals (dogs and cats) and some equine applications; sales typically occur through veterinary distributors, clinic direct sales, and partner channels.
• Headquarters and workforce: Zomedica is U.S.-based; headcount and facility details are disclosed periodically in company filings and investor updates.

For an authoritative company profile and the latest operational details, refer to Zomedica’s investor relations materials and SEC or OTC filings, which record headcount, facility locations, product rollouts, and other corporate disclosures.

Stock and market listing

Zomedica stock trades on the over-the-counter markets and is commonly quoted under the ticker ZOMDF. OTC listing means quotes and trades are recorded on an OTC marketplace rather than on a national securities exchange.

Important points about OTC quotation and zomedica stock:

• Ticker symbol: ZOMDF (OTCQB/OTC markets tiering is often referenced on market pages).
• Exchange/quasi-exchange context: OTC quotations typically appear on OTC market data pages and are aggregated by major finance portals. Pricing and volume data for OTC securities can be less liquid and may have reporting delays compared with national exchange listings.
• Historical tickers and listings: companies can have prior tickers or have previously been listed on other venues; consult company filings or investor relations for any historical listing changes.

Ticker symbols and class of shares

• Primary ticker for common shares: ZOMDF (over-the-counter quotation).
• Share classes: Zomedica historically issues common shares; if other classes (preferred shares, special warrants) exist, they are described in the company’s capitalization table and filings.
• OTCQB vs major exchange: an OTCQB listing provides a public quotation environment but lacks some of the regulatory and liquidity features of major exchanges. Investors in zomedica stock should note differences in trade execution certainty, reporting frequency, and broker handling of OTC securities.

Trading data and price history

Trading characteristics for zomedica stock typically include lower liquidity than large-exchange securities, potentially wider bid-ask spreads, and daily volume that can vary greatly with news or retail interest.

• Price behavior and recent ranges: price swings for OTC-traded names can be large over short periods. For current intraday and historical prices, financial portals provide quote snapshots while historical time series can be sourced via specialized chart providers.
• 52-week high/low and averages: these metrics are updated continuously on major finance pages; check the most recent chart providers for exact 52-week ranges.
• Liquidity characteristics: average daily volume and trade count metrics appear on market-data pages; OTC-listed names may show thin trading on many days and spikes around corporate news or retail attention.
• Market capitalization trends: market cap for zomedica stock is computed as price times outstanding shares and can shift materially as price moves or as the company issues or buys back shares.

Historical price performance

Long-term historical peaks and troughs for zomedica stock reflect a combination of product news, corporate updates, broader market sentiment toward small-cap biotech/veterinary names, and retail interest. Historical daily, weekly, and monthly charts are available from data aggregators and specialized providers.

As of 2026-01-27, historical price data can be reviewed on market-data aggregators and chart services (e.g., OTC Markets, Yahoo Finance, Macrotrends). Those sources allow users to examine multi-year trends, identify volume spikes, and correlate price movements with corporate events.

Financials and key metrics

Financial metrics for Zomedica (revenue, profitability, cash position, EPS, market cap, P/S, P/B) are reported in periodic filings and summarized on financial portals. Because these numbers change with each quarterly or annual filing, use the most recent 10-Q or 10-K and company press releases for authoritative figures.

• Revenue and profitability: Zomedica’s top-line and bottom-line performance depends on product sales, recurring consumable revenue, and R&D or commercialization expenses. Public filings provide the latest reported sales and net income (or loss).
• Cash and liquidity: the company discloses cash, short-term investments, and debt levels in quarterly reports; liquidity is a key indicator for execution of commercial plans.
• Per-share metrics: EPS, diluted share count, and outstanding shares are documented in filings; earnings per share can be negative for companies investing heavily in commercialization.
• Valuation multiples: market-derived ratios (market cap / revenue, P/S, P/B) should be recalculated using current market price and the most recent financial figures.

Recent financial results

As of 2026-01-27, the most recent quarterly and annual results for Zomedica should be consulted in the company’s investor relations and quarterly filings. These documents contain reported revenue, gross margin, operating expenses, net income or loss, and disclosed cash balances.

Source references for recent financials include the official investor relations page and the company’s regulatory filings; aggregated summaries are available on major finance portals and research platforms.

Business operations and products

Zomedica’s revenue drivers and commercial strategy center on point-of-care diagnostics and associated consumables for veterinary settings. Core aspects of operations include:

• TRUFORMA platform and instruments: diagnostic platforms intended for rapid, in-clinic testing and decision support.
• Consumables and recurring revenue: many diagnostics companies rely on consumable test cartridges, reagents, or disposables to build recurring revenue streams from installed base.
• Sales channels: distribution through veterinary distributors, direct sales to clinics, partnerships, and digital outreach.
• Research & development: ongoing product improvements, new assay development, and device enhancements are typically disclosed in R&D expense lines and investor presentations.

Near-term commercial catalysts for zomedica stock can include product launches, expanded distribution agreements, key regulatory clearances (if applicable), and demonstrable consumable revenue growth.

Corporate governance and management

Corporate governance for Zomedica includes a board of directors, executive management (CEO, CFO, and other officers), and delegated committees. Key governance documents and proxy statements describe board composition, executive compensation, and governance policies.

• Executive roles: the CEO oversees strategy and commercialization; the CFO manages finance, reporting, and capital allocation. Specific names and biographies are available in the company’s investor materials.
• Board oversight: independence, board committees (audit, compensation, nominating), and meeting frequency are disclosed in proxy filings.

For the most current governance details and executive biographies, review the company’s latest proxy statement and investor relations page.

Regulatory filings and investor communications

Primary documents for zomedica stock include periodic filings and company-issued communications:

• Filings: annual reports (10-K), quarterly reports (10-Q), current reports (8-K), and proxy statements are authoritative for financial and corporate information.
• Investor communications: press releases, investor presentations, and shareholder letters provide context and management commentary.

As of 2026-01-27, official filings and press releases published by Zomedica are the primary sources to verify reported revenue, cash balances, corporate actions, and management discussion and analysis.

Analyst coverage and market commentary

Coverage of zomedica stock comes from a mix of professional analysts, independent research platforms, and retail communities.

• Professional research: select sell-side analysts and independent equity research services may publish reports; coverage intensity can be limited for OTC-traded small caps.
• Aggregators: platforms like Seeking Alpha and major finance portals aggregate news, editorial analysis, and commentary.
• Retail sentiment: community platforms such as StockTwits often host real-time retail discussion, trade ideas, and event-driven commentary.

Note: analyst ratings and retail commentary vary in quality and perspective. Always corroborate third-party commentary with official filings and trusted data before forming conclusions.

Ownership and share structure

Ownership of zomedica stock typically falls into three broad categories: insiders, institutions, and retail investors. Important aspects of share structure include outstanding shares, float, insider holdings, and potential dilution from convertible securities or financing activities.

• Outstanding shares and float: the company’s filings disclose the number of shares outstanding. Float excludes restricted shares and large insider holdings that are not freely traded.
• Insider ownership: directors and officers disclose their holdings in proxy and periodic filings; insider activity (purchases or sales) is reported publicly.
• Institutional ownership: institutions that report positions in OTC securities may be listed in aggregated data on finance portals; institutional presence can influence liquidity and stability.
• Dilution risk: financing via equity offerings, warrants, or convertible instruments can increase share count and affect per-share metrics. Filings reveal authorized shares and recent financings.

Risks and investment considerations

This section outlines typical risks associated with investing in OTC-traded veterinary and medical-equipment companies such as Zomedica. The list is informational and not investment advice.

• Commercialization risk: product adoption in veterinary clinics may be slower than expected; achieving repeatable consumable revenue is critical.
• Regulatory risk: product clearances or certifications may be necessary for broader market access; regulatory outcomes can affect revenue timelines.
• Competitive risk: other diagnostics and device makers may compete on price, features, or distribution.
• Concentration risk: reliance on a small number of products, customers, or partners can make revenue streams vulnerable.
• Liquidity and market structure risk: OTC trading often involves lower liquidity, wider spreads, and greater price volatility.
• Execution and financial risk: companies in commercialization phases may require additional capital; financing on dilutive terms can impact existing holders.
• Information risk: OTC disclosure standards differ from major exchanges; investors should rely on company filings and reputable aggregators for verified facts.

Investors and researchers should review the company’s risk factors (commonly included in annual reports and prospectuses) for a detailed and authoritative enumeration of company-specific risks.

Corporate events and recent developments

Material events that can drive movement in zomedica stock include product launches, distribution agreements, regulatory clearances, earnings releases, executive changes, or significant financings.

• As of 2026-01-27, recent company announcements and press releases (reported on the company’s investor relations page and OTC Markets) are primary sources to identify recent launches, partnerships, or management changes.
• Trading halts and corporate actions: any trading halts, reverse splits, or share consolidations are typically announced in filings and press releases; check the issuer’s filings for precise dates and terms.

Maintain a timeline of corporate events when researching the zomedica stock to correlate market reactions with factual developments.

Comparison and peers

When comparing Zomedica to peers, consider firms in veterinary diagnostics, point-of-care testing, and small-cap medical device companies. Useful comparative metrics include revenue growth, consumable attach rate, installed base, gross margins, and R&D intensity.

Common peer-comparison metrics:

• Revenue growth rate and mix (product vs consumables)
• Installed base and replacement cycle for devices
• Gross margin and contribution margin on consumables
• Cash runway and capital structure
• Market capitalization relative to revenue (P/S)

Peer selection should account for company scale, geographic footprint, and product focus (companion animal diagnostics vs broader human diagnostics).

See also

• Veterinary diagnostics
• OTC Markets and quotation tiers
• TRUFORMA and point-of-care diagnostic platforms
• Industry peers in veterinary medical devices

References

• Zomedica Investor Relations — stock information and investor communications (company filings and press releases). As of 2026-01-27, investor relations materials are the primary disclosure source for the zomedica stock.
• OTC Markets — ZOMDF overview and market quotes. As of 2026-01-27, OTC Markets provides quotation data and market-tier information for ZOMDF.
• Yahoo Finance — ZOMDF quote and company profile. As of 2026-01-27, Yahoo Finance provides aggregated quote snapshots, basic financial summaries, and 52-week ranges.
• Seeking Alpha — company page and user-generated insights and articles. As of 2026-01-27, Seeking Alpha aggregates research notes and community commentary on ZOMDF.
• CNBC — ZOMDF quote and key stats. As of 2026-01-27, CNBC provides a quick overview of key market metrics for the zomedica stock.
• Macrotrends — historical price charts and time series for ZOMDF. As of 2026-01-27, Macrotrends offers downloadable historical price data and long-term charts.
• StockTwits — retail community sentiment and real-time conversation about ZOMDF. As of 2026-01-27, StockTwits hosts investor discussion and social sentiment flows.
• Markets Insider / Business Insider — snapshot pages for ZOMDF. As of 2026-01-27, Markets Insider aggregates market data and news headlines.

Note: All numerical and time-sensitive items should be validated by consulting the listed primary sources for the latest figures.

External resources and where to get live data

To obtain live quotes, historical charts, up-to-date SEC/OTC filings, and official company announcements for zomedica stock, use the following types of resources:

• Company investor relations materials and press releases (official disclosures and presentations).
• OTC Markets issuer page for quotation details and disclosure filings.
• Major finance portals for aggregated quotes and 52-week statistics.
• Regulatory filing repositories for 10-Q, 10-K, 8-K, and proxy statements.

As of 2026-01-27, OTC Markets and the company’s investor relations page remain the most direct sources for the zomedica stock’s official disclosures.

How to research and monitor zomedica stock — a practical checklist

1. Start with official filings: read the most recent 10-K and 10-Q for complete financial statements and risk factors.
2. Review recent press releases and investor presentations for product and commercialization updates.
3. Check OTC Markets for the latest quotation tier status and any company-submitted disclosure documents.
4. Use data aggregators for historical price charts, average volume, and market cap snapshots; verify any critical figures in the filings.
5. Monitor community commentary on platforms like StockTwits and curated research on Seeking Alpha, but treat these as supplementary to official documents.
6. Track insider transactions and financing activity disclosed in filings to assess dilution and insider alignment.
7. For trading or building a watchlist, consider the liquidity characteristics and spreads common to OTC-traded securities.

Responsible use and a note on trading channels

If you decide to follow or trade zomedica stock, use regulated brokerage services and confirm whether your chosen platform supports OTC securities. For users seeking broader market access and a managed trading environment, Bitget offers market tools and wallet integrations to research and manage positions.

Remember: this article provides factual background and research guidance but does not provide investment advice. Always verify figures and consult professional advisors before making investment decisions.

Further explore zomedica stock information through the company’s investor relations and the market-data pages listed in the References section. For trading, research available broker platforms and, if appropriate, consider Bitget’s tools and wallet solutions to help organize and track holdings.

Updated: 2026-01-27. Reported source references include company investor relations, OTC Markets, Yahoo Finance, Seeking Alpha, CNBC, Macrotrends, StockTwits, and Markets Insider. All date-sensitive figures should be retrieved from the cited primary sources for confirmation.